Concepedia

Expanded Access Use

Expanded Access Use is an investigational device exemption pathway that permits the use of a non-approved medical device outside of clinical trials for patients with serious or immediately life-threatening conditions who lack comparable alternative treatment options, under circumstances ensuring patient safety and data collection for regulatory evaluation.

215

Publications

10.6K

Citations

1.7K

Authors

869

Institutions

Publications per year

2017–2026

96

Variants

Compassionate Use

Parents

Publications

215

Six Randomized Evaluations of Microcredit: Introduction and Further Steps

Abhijit Banerjee, Dean Karlan, Jonathan Zinman · American Economic Journal Applied Economics · 2015 · 976 citations · Full text

, , +17

Considerations for the Use of Phage Therapy in Clinical Practice

Antimicrobial Agents and Chemotherapy · 2022 · 363 citations · Full text

, , +17

Drug Resistance Mutations in HIV-1.

Richard T. D’Aquila · PubMed · 2003 · 282 citations

, , +17

Expanded Access to Highly Active Antiretroviral Therapy: A Potentially Powerful Strategy to Curb the Growth of the HIV Epidemic

Viviane D. Lima, Karissa Johnston, Robert S. Hogg et al. · The Journal of Infectious Diseases · 2008 · 211 citations

, , +15

Long‐term safety and treatment effects of cannabidiol in children and adults with treatment‐resistant epilepsies: Expanded access program results

Jerzy P. Szaflarski, E. Martina Bebin, Anne M. Comi et al. · Epilepsia · 2018 · 205 citations · Full text

, , +17

1–5 of 215

Authors

1.7K

  1. KM
    Karen MacDonald

    Matrix Research (United States), United States

    5 publications · 129 citations

    5

    h-index

  2. DG
    Diana Giannarelli

    Istituti di Ricovero e Cura a Carattere Scientifico, Italy

    5 publications · 393 citations

    5

    h-index

  3. AB
    Alison Bateman-House

    NYU Langone Health, United States

    5 publications · 112 citations

    5

    h-index

  4. PA
    Paolo A. Ascierto

    Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Italy

    5 publications · 190 citations

    5

    h-index

  5. MM
    Michele Maio

    University of Siena, Italy

    4 publications · 178 citations

    4

    h-index

1–5 of 1.7K

Institutions

869

  1. Harvard University

    Cambridge, United States

    10 h-index

    41 publications

    1.5K citations

  2. Istituti di Ricovero e Cura a Carattere Scientifico

    Rome, Italy

    10 h-index

    14 publications

    609 citations

  3. Memorial Sloan Kettering Cancer Center

    New York, United States

    10 h-index

    29 publications

    879 citations

  4. Massachusetts General Hospital

    Boston, United States

    9 h-index

    72 publications

    3.1K citations

  5. Fondazione IRCCS Istituto Nazionale dei Tumori

    Milan, Italy

    9 h-index

    17 publications

    1.7K citations

  6. Dana-Farber Cancer Institute

    Boston, United States

    8 h-index

    10 publications

    704 citations

  7. Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"

    Naples, Italy

    8 h-index

    10 publications

    596 citations

  8. University of California, San Francisco

    San Francisco, United States

    7 h-index

    20 publications

    735 citations

1–8 of 869

Venues

  1. Journal of Clinical Oncology

    11 publications · 415 citations

    11

    h-index

  2. PubMed

    Repository · 9 publications · 574 citations

    9

    h-index

  3. Lung Cancer

    6 publications · 260 citations

    6

    h-index

  4. European Journal of Cancer

    4 publications · 172 citations

    4

    h-index

  5. Journal for ImmunoTherapy of Cancer

    JITC · 4 publications · 277 citations

    4

    h-index

1–5